title: Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series.
authors: Marco
authors: M
authors: Di Nicola
authors: Daniela
authors: D
authors: Tedeschi
authors: Giovanni
authors: G
authors: Martinotti
authors: Ofelia
authors: O
authors: De Vita
authors: Marisa
authors: M
authors: Monetta
authors: Gino
authors: G
authors: Pozzi
authors: Luigi
authors: L
authors: Janiri
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000503:physiopathology; D000069583:Pregabalin; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D012720:Severity of Illness Index; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D000069583:Pregabalin; D017367:Selective Serotonin Reuptake Inhibitors; D005680:gamma-Aminobutyric Acid